Regarding histone modifications, it has been stated that non-invasive PitNETs express higher amounts of the anti-PRDM2 antibody (RIZ1), acting as tumor suppressors and as histone methyltransferase in comparison to invasive PitNETs [72]. Here, PRDM2 is linked to neoplasm.